Will the patent for Botox ever expire?

Botox is no longer on patent.  The active component is used by several other manufacturers in products such as Dysport, Xeomin, and some newer products that will be in the US sometime in the future.

Xeomin and Dysport are two alternative products to Botox. The price point is similar to Botox. There are a variety of dermal fillers on the market. Most dermal fillers are within the same price range as well. With Botox and filler remember you are not only paying for the product, but the expertise. All the Best. 

Two equivalent alternatives to Botox that I use in my practice are Xeomin and Dysport.  Xeomin is known as being a pure form of botulinum toxin as it doesn't have any linking proteins.  Dysport is know for having a greater "spread" effect upon injection.  I actually prefer to use a combination of Botox and alternatives in my practice.  For example, because of the greater "spread", I think Dysport is great for the crow's feet area.  The price is equal for all three in my practice.  However, Allergan's (makers of Botox) brilliant distinctions program offers some discount to the patient and Merz (makers of Xeomin) and Galderma (makers of Dysport) have some incentives for loyal repeat patients as well.  All three are luxury procedures, so I don't see the price dropping anytime soon.  I feel only "core" injectors should perform cosmetic injectables (facial
plastic surgeons, plastic surgeons, dermatologists, or occuloplastic
surgeons). This is because we all have a keen understanding of facial
anatomy and the effects of injecting Botox/ Xeomin/ Dysport and fillers in different
regions of the face. Be sure you are seeing one of us, and I wish you well!

Botox is not on patent because there are two other companies in the USA which produce botulinum toxin to be used for cosmetic purpose just like Botox

There is no generic Botox, however
there are other types of injectable toxins that are used to improve the look of
moderate to severe lines in adults.

Botox is made by
Allergan the makers of Juvederm, Voluma and Latisse. Botox works by blocking nerve impulses to the
injected muscles. This reduces muscle activity that causes moderate to severe
lines to form. I prefer to inject this in the forehead region.

Dysport is made by
Valient the makers of Sculptra, Restylane and Perlane. Dysport’s molecule is
slightly smaller than Botox and Xeomin and therefore has more “spread.” I
prefer to inject Dyport around the crow’s feet area because of this.

Xeomin is made by Merz
the makers of Radiesse and Belotero. This is the newest toxin and does not
contain a complex protein that Botox and Dysport contain that you can
eventually become resistant to. If Botox is not lasting as long as a patients
would like then I inject them with Xeomin to see if it is better suited for
them.

Ultimately, I base my
decision as to which one to use by the patient’s history and lifestyle as I
offer all at my practice. Ultimately they are all about the same price. Each
company also offers several different filler options, fillers vary in price
based on density and longevity of the product.

Consult with a Board
Certified Dermatologist to see which option is best for you concerns.For more information click on link below:

Hi btwhitley88:

You
are well versed in Botox history!

The
idea of a generic drug is one that is the same molecule made off-patent,
usually by another manufacturer.

Dysport
and Xeomin are the same molecule made by different manufacturers but not
cheaper.

Hyaluronic
Acid fillers such as Juvederm (Ultra, Ultra Plus, Voluma) and the family of
Restylane and Perlane are similar HA molecules with different linking chains
providing different durations of longevity.

The
answer to your question maybe based on the passage of FDA requirements of these
drugs and devices to be marketed in the United States and why Chinese and other
non-FDA generic and similar injectibles are so vigorously disapproved here. You
may question the Consumer Division of Allergan, Galderma, Merz and other
manufacturers and licensing Pharmaceuticals but my guess is it would be
counter-productive to their bottom line.

Good
question! 

Although there is not a "genric" Botox, there are other companies making what I would consider to be a pretty equivalent product. Dysport was approved years ago and hen Xeomin. I do think that these can be gotten for a better price in many areas as the companies that market these seem to be more flexible with their pricing;at least that has been my personal; experience. Allergan does have the Brilliant Distinctions program that helps with pricing for loyal patients